cilostazol has been researched along with fibrinogen in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hashimoto, A; Nishikawa, M; Ohashi, K; Okuda, M; Onoda, K; Shimono, T; Shimpo, H | 1 |
Conran, N; Costa, FF; Franco-Penteado, CF; Proença-Ferreira, R; Saad, ST; Traina, F | 1 |
1 trial(s) available for cilostazol and fibrinogen
Article | Year |
---|---|
Inhibition of platelet aggregation by combined therapy with aspirin and cilostazol after off-pump coronary artery bypass surgery.
Topics: Aged; Aspirin; Cilostazol; Coronary Artery Bypass, Off-Pump; Drug Therapy, Combination; Female; Fibrinogen; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Platelet Function Tests; Tetrazoles; Thrombosis; Time Factors; Treatment Outcome; von Willebrand Factor | 2008 |
1 other study(ies) available for cilostazol and fibrinogen
Article | Year |
---|---|
Increased adhesive properties of platelets in sickle cell disease: roles for alphaIIb beta3-mediated ligand binding, diminished cAMP signalling and increased phosphodiesterase 3A activity.
Topics: Adult; Aged; Anemia, Sickle Cell; Blood Platelets; Cells, Cultured; Cilostazol; Collagen; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Female; Fibrinogen; Humans; Male; Middle Aged; Phosphodiesterase 3 Inhibitors; Phosphodiesterase Inhibitors; Platelet Adhesiveness; Platelet Glycoprotein GPIIb-IIIa Complex; Tetrazoles; Young Adult | 2010 |